Unigold Inc. heads into its May 1 earnings release with an awkward setup: the stock has climbed 14% over the past month to CAD 0.44, yet its own CEO spent most of March selling into that strength.
The insider activity is the defining feature of this week's picture. Chairman and CEO Joseph Hamilton sold shares on at least seven separate occasions between March 17 and March 23, offloading roughly 1.165 million shares at prices ranging from CAD 0.36 to CAD 0.42. The aggregate value across those transactions exceeded CAD 290,000. Former director Charles Page sold a further 75,000 shares on March 23. Set against those sales, a director purchase on February 25 — nearly 3.9 million shares at CAD 0.18 — stands out as the one clear accumulation signal, representing the largest single insider transaction in the period. The net 90-day insider balance is positive in share terms, but that director buy at a much lower price tells a different story from the CEO activity closer to current levels. The company also granted 600,000 new options on April 28, the day before earnings, adding further share-count context for investors watching dilution.
Short positioning has collapsed in a way that removes most of the bearish technical pressure. Estimated short interest dropped more than 94% over the past month, from roughly 750,000 shares in early April to just 41,000 today. The borrow market reflects that shift: cost to borrow is a negligible 1.22%, and availability has eased considerably from a 52-week high utilization reading of 88% to roughly 12% utilization now. There is no squeeze dynamic here, and no meaningful short-side conviction apparent in the lending data.
The ORTEX short score of 29.9 — in the 66th percentile among peers for short score rank — is broadly consistent with that picture: moderate positioning, not extreme. Days to cover is just one day. The analyst data on file is more than four years old and therefore excluded from this note. The only valuation reference available is an enterprise value of approximately CAD 54 million as of year-end 2025, which is stale but at least directional context for a stock priced at CAD 0.44.
Peers on the TSXV have had a mixed week. RYO was flat on the week while AE slipped nearly 1%. Neither diverges sharply from UGD's 8.6% weekly gain, but UGD's move is clearly outpacing the immediate peer group — which makes the CEO's earlier decision to sell in the CAD 0.36–0.42 range look notable in hindsight.
The May 1 earnings release is now the focal point. Past prints have produced wide single-day swings — a 15% move in September 2025, a 5.6% gain in November — suggesting the stock is capable of large reactions to news. Whether the director's large February buy or the CEO's March selling cluster better reflects the company's near-term trajectory is the question the earnings release will begin to answer.
See the live data behind this article on ORTEX.
Open UGD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
